Biotech and healthcare companies operating in the new technology industry face limitations in investing and raising funds to increase corporate value due to their small size, burdened with “initial investment costs” and “lack of specialized manpower.”Therefore, the government should provide institut
Seoul Metro initiated a trial run of seatless subway cars on Line 4 to alleviate congestion during peak hours. This initiative reflects the competitive nature of Korean society, akin to a game of musical chairs. In this game, participants fiercely vie for a limited number of chairs, with those unabl
Pfizer Korea and Hanlim MS said they entered into a co-marketing agreement for the drug Xeljanz (ingredient: tofacitinib citrate), a drug used in the treatment of various autoimmune diseases.This collaboration aims to expand the availability and benefits of Xeljanz to a wider patient demographic thr
Over 3,000 doctors are generated annually in Korea, yet a declining number are actively seeking specialized qualifications. Particularly noteworthy is the reduction of physicians specializing in critical departments that deliver essential care, with a decrease of 610, or 24 percent, observed over th
CHA Vaccine Institute, a subsidiary of CHA Biotech, has disclosed the top-line results from the phase 1 clinical trial of its third-generation hepatitis B vaccine candidate, CVI-HBV-002, which showed that the candidate had higher efficacy compared to currently available vaccines. The announcement pr
A mother's diagnosis of breast cancer at a young age does not significantly affect her children's emotional development, according to a new study.Professor Kim Hee-jeong of the Department of Breast Surgery and Professor Kim Hyo-won of the Department of Pediatric Psychiatry at Asan Medical Center (AM
CG Bio, a regenerative medicine company, said Wednesday that it has launched Easydew MD cream 200g, which strengthens the skin barrier.The skin barrier is the outer layer of the skin that protects the skin from external threats such as infectious agents, chemicals, systemic toxins, and allergens.Eas
Bridge Biotherapeutics said Tuesday that the Independent Data Monitoring Committee (IDMC) has recommended the company continue conducting phase 2 clinical trial of BBT-877, its candidate for treating idiopathic pulmonary fibrosis (IPF).According to the company, the IDMC was held to review the safety
Psoriasis is a chronic immune disorder in which the skin's immune cells interact incorrectly, resulting in overactive T-cells and thick, flaky skin.Despite being well controlled, psoriasis can worsen if patients lower their guard. Its aggravation can be caused by discontinuing or by various external
Yonsei University Health System (YUHS) said it signed a collaborative agreement with KURE.AI Therapeutics, a U.S. biotech firm, to cooperate on the development of cell therapies.Under this partnership, the two institutions plan to establish a company focused on developing cell therapies for solid tu
AstraZeneca Korea said Wednesday that it has signed an agreement with HK inno.N, a Kosdaq-listed healthcare company, to co-promote Forxiga's combination drugs, Xigduo XR (dapagliflozin + metformin) and Sidapvia Tab (dapagliflozin + sitagliptin), and to distribute Forxiga (dapagliflozin) in Korea.Und
Celltrion held an orientation for biotech startup companies selected through the Seoul Biohub-Celltrion Open Innovation Program on Tuesday at its Global Biotechnology Research Center in Songdo, Incheon.The Seoul Biohub-Celltrion Open Innovation Program fosters and supports biotech and medical startu
Phantomics said Tuesday that the company has received a medical device marketing authorization from the Thai Food and Drug Administration (TFDA) for its non-invasive cardiomyopathy diagnostic solution, Myomics.Myomics, launched by Phanthomics in 2020, is a service that non-invasively extracts dozens
JLK, a Kosdaq-listed medical AI company, said Wednesday that it had been granted a U.S. patent for its device and method for providing brain lesion information.The patent is a technology patent for a method that can accurately learn and analyze brain lesion areas in three-dimensional magnetic resona
Boehringer Ingelheim Korea said it has commenced a voluntary recall of select batches for Spiriva Respimat (ingredient: tiotropium bromide hydrate), its chronic obstructive pulmonary disease (COPD) and asthma medication.This medication is approved for use as a bronchodilator in the maintenance treat
Seoul National University Bundang Hospital (SNUBH) has been acknowledged for its efforts in catering to international patients, particularly following its second consecutive Global Health Accreditation (GHA) certification received in November of the previous year.The GHA certification recognizes the
In a recent media session organized by MSD Korea, a local professor shared insights regarding the efficacy of MSD's Lagevrio (ingredient: molnupiravir) in treating Covid-19, with a particular focus on high-risk groups.As the global community continues to recover from the pandemic, the Covid-19 virus
Bayer Korea's treatment for chronic kidney disease with type 2 diabetes, Kerendia (finerenone), will be covered by health insurance for adult patients starting next month.Kerendia is a first-in-class non-steroidal selective antagonist of the mineralocorticoid receptor, a novel mechanism of action th
Dong-A Pharmaceutical said Tuesday that it has launched a seven-day supply of Orthomol Vital M (for men) and Orthomol Vital F (for women), premium vitamin supplements from German nutraceutical company Orthomol.Orthomol Vital is a nutraceutical brand officially imported and sold in Korea by Dong-A Ph
President Yoon Suk Yeol said non-face-to-face medical treatment should be viewed from the perspective of developing the bio-medical industry, emphasizing that the government would pursue policies to attain administrative goals by fostering related industries rather than regulating them.President Yoo